We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+51.15%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$164M
AUM Growth
-$161M
Cap. Flow
-$193M
Cap. Flow %
-117.42%
Top 10 Hldgs %
81.58%
Holding
31
New
8
Increased
4
Reduced
9
Closed
5

Top Buys

Rank Stock Value
1
EYPT icon
EyePoint Inc
EYPT
+$4.49M
2
SWTX
SpringWorks Therapeutics
SWTX
+$4.1M
3
BHVN icon
Biohaven
BHVN
+$3.39M
4
TDOC icon
Teladoc Health
TDOC
+$2.08M
5
ARDX icon
Ardelyx
ARDX
+$516K

Sector Composition

Rank Sector Weight
1 Healthcare 55.58%
2 Energy 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INKT icon
26
MiNK Therapeutics
INKT
$54.6M
$39.5K 0.02%
3,690
MNKD icon
27
MannKind Corp
MNKD
$1.32B
-300,000
Closed -$1.24M
OPK icon
28
Opko Health
OPK
$1.02B
-450,564
Closed -$721K
QDEL icon
29
PUT
QuidelOrtho
QDEL
$838M
-100,000
Closed -$7.3M
OMGA
30
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
-50,000
Closed -$108K
NSTG
31
DELISTED
NanoString Technologies, Inc.
NSTG
-485,886
Closed -$836K

Similar funds

Oracle Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Oracle Investment Management held 31 positions worth $164M, down 50% from $326M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Oracle Investment Management withdrew a net $193M in Q4 2023, closing 5 positions and reducing 9 holdings. Its most notable exit was MannKind Corp, an estimated $1.24M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 20% a quarter earlier, followed by Energy.

Against the trend, Oracle Investment Management opened a new position in EyePoint Inc worth $9.28M.

  • Oracle Investment Management's largest Q4 2023 buy was EyePoint Inc: 401,557 shares worth $9.28M.
  • Oracle Investment Management added most to Biohaven in Q4 2023, an estimated $3.39M increase.
  • Oracle Investment Management's biggest Q4 2023 reduction was Pacific Biosciences, cutting an estimated $2.14M.
  • Oracle Investment Management fully exited MannKind Corp in Q4 2023, selling an estimated $1.24M.
  • Oracle Investment Management's ten largest holdings make up 82% of its $164M portfolio in Q4 2023.
  • Oracle Investment Management opened 8 new positions and closed 5 in Q4 2023.
  • Oracle Investment Management's portfolio value fell 50% quarter-over-quarter to $164M.

Based on Oracle Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.